A study by Palladino et al. (2009) found no significant differences in mean CSF tau levels between ALS cases and controls (ALS 126 pg/ml, controls 112 pg/ml), however, in the ALS group, bulbar-onset patients showed elevated CSF tau levels compared to spinal-onset cases. The gene discussed is MAPT; the disease is amyotrophic lateral sclerosis.